文献速递艾滋病与性传播感染

肯尼亚住院HIV感染儿童巨细胞病毒血症与临床结局

Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital.
PubMed 文献 · Clin Infect Dis · 2022-01-01

研究纳入163名2月龄至12岁在医院确诊HIV的肯尼亚儿童,采用定量PCR检测血浆CMV DNA。54%患儿存在CMV血症,≥1000 IU/mL与15天死亡或持续住院风险增加及住院时间延长独立相关。

要点

  • 住院确诊HIV的肯尼亚儿童中CMV血症常见,54%可检出。
  • CMV DNA≥1000 IU/mL与15天死亡或持续住院风险升高相关(RR 1.74)。
  • CMV DNA≥1000 IU/mL者住院时间中位延长约5天。

核心结论

  • 住院HIV感染儿童中CMV血症常见,≥1000 IU/mL与死亡或持续住院风险增加及住院时间延长相关。

研究设计与样本

  • 嵌套观察性研究,纳入163名2月龄至12岁在医院确诊HIV的肯尼亚儿童。
  • 采用定量PCR检测血浆CMV DNA,并用回归模型评估CMV血症≥1000 IU/mL与临床结局的关联。

主要发现

  • 入组时62/114(54%)儿童有CMV血症,其中20(32%)≥1000 IU/mL。
  • 入院后观察到11例CMV再激活。
  • CMV血症的患病率和水平在<2岁儿童中最高,在≥5岁儿童中最低。
  • 调整年龄和log10 HIV RNA后,CMV DNA≥1000 IU/mL者15天死亡或持续住院的相对风险为1.74(95%CI 1.04–2.90)。

临床怎么用

  • 对住院确诊HIV的儿童,尤其<2岁者,应考虑CMV血症检测以识别高风险患者。
  • CMV DNA≥1000 IU/mL提示死亡或持续住院及住院时间延长风险增加,需加强监测与干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cytomegalovirus (CMV) viremia is common in human immunodeficiency virus (HIV) infection and is associated with worse long-term outcomes. To date, no studies have assessed CMV viremia in children diagnosed with HIV in hospital. METHODS: We studied CMV viremia and clinical outcomes in 163 Kenyan children aged 2 months to 12 years, diagnosed with HIV in hospital. CMV DNA levels in plasma were measured using quantitative polymerase chain reaction (PCR). Regression models were used to assess associations between CMV viremia ≥1000 IU/mL and the risk of continued hospitalization or death at 15 days, duration of hospitalization, and 6-month mortality. RESULTS: At enrollment, 62/114 (54%) children had CMV viremia, and 20 (32%) were ≥1000 IU/mL. Eleven CMV reactivations were observed after admission. The prevalence and level of CMV viremia were highest in children <2 years and lowest in children ≥5 years old. CMV viremia ≥1000 IU/mL was independently associated with age <2 years (P = .03), higher log10 HIV RNA level (P = .01), and height-for-age z score >-2 (P = .02). Adjusting for age and log10 HIV RNA, the relative risk of death or continued hospitalization at 15 days was 1.74 (95% confidence interval [CI] = 1.04, 2.90), and the hazard ratio of 6-month mortality was 1.97 (95% CI = .57, 5.07) for children with CMV DNA ≥1000 IU/mL compared to lower-level or undetectable CMV DNA. Children with CMV DNA ≥1000 IU/mL were hospitalized a median ~5 days longer than children with lower-level or undetectable CMV DNA (P = .002). CONCLUSIONS: In this nested observational study, CMV viremia was common in hospitalized children with HIV, and levels ≥1000 IU/mL were associated with increased risk of mortality and longer hospitalization.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wamalwa D, Njuguna I, Maleche-Obimbo E, et al. Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital. Clin Infect Dis. 2022. PMID: 34214163. doi:10.1093/cid/ciab604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。